Nachrichten zur Moderna Inc. Aktie

Moderna, Inc. (MRNA) Guggenheims Inaugural Healthcare Innovation Conference (Transcript)

…

Bloomberg Markets 11/15/2024

"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street. Todays…

Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more

These are the stocks posting the largest moves in midday trading.…

Apple, Moderna, Applied Materials fall premarket; Alibaba, Dominos Pizza rise By Investing.com

Apple, Moderna, Applied Materials fall premarket; Alibaba, Dominos Pizza rise…

Pfizer, BioNTech & Co: Trump-Ankündigung setzt Aktien unter Druck

Die Aktien von Impfstoff-Unternehmen stehen zum Wochenschluss deutlich unter Druck. Sowohl Moderna, als auch BioNTech, Pfizer und Novavax notieren im…

Pfizer, BioNTech & Co: Trump-Ankündigung setzt Aktien unter Druck

Die Aktien von Impfstoff-Unternehmen stehen zum Wochenschluss deutlich unter Druck. Sowohl Moderna, als auch BioNTech, Pfizer und Novavax notieren im…

Moderna Aktie: Begrenztes Aufwärtspotenzial und strukturelle Herausforderungen

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Wolfe Research: 1. Zusammenfassung der Bewertung Wolfe Research bewertet die Aktie von Moderna Inc. (ISIN: US60770K1079,…

PLTR, MRNA, PFE, BABA, TSLA: Top 5 Trending Stocks Today - Alibaba Gr Hldgs (NYSE:BABA), Moderna (NASDAQ:MRNA)

US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling…

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

Shares of Moderna, Novavax, Pfizer, BioNTech and GSK closed lower on Thursday.…

Moderna, Inc. (MRNA) UBS Global Healthcare Conference (Transcript)

…

Inside Moderna’s Tech-Driven Culture: Insights From CIO Brad Miller

Brad Miller, Modernas CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue pharmaceutical…

Modernas Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn

…

Moderna Aktie: Nachfrage-Rückgang bei COVID-Impfungen - Kursziel revidiert

Toronto (www.aktiencheck.de) - Moderna-Aktienanalyse von RBC Capital Markets: Aktuelle Bewertung RBC Capital hat das Kursziel für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…

Wall Street Has Best Fed Day of 2024 | Bloomberg: The Close 11/07/2024

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after…

Moderna (MRNA) Q3 2024 Earnings Call Transcript

MRNA earnings call for the period ending September 30, 2024.…

Moderna (MRNA) Q3 2024 Earnings Call Transcript

…

Stocks making the biggest moves premarket: Lyft, SolarEdge, Qualcomm, Moderna and more

These are the stocks posting the largest moves in premarket trading.…

Moderna, Inc. 2024 Q3 - Results - Earnings Call Presentation

…

Moderna mit überraschend gutem Quartal - Covid-Impfung bleibt gefragt

CAMBRIDGE (dpa-AFX) - Der Covid-Impfstoffhersteller Moderna hat ein unerwartet gutes Quartal hinter sich. Der neueste Booster…

Warner Bros, Moderna, Under Armour and Lyft rise premarket By Investing.com

Warner Bros, Moderna, Under Armour and Lyft rise premarket…

Moderna shares surge after vaccine makers posts shallower-than-expected loss By Investing.com

Moderna shares surge after vaccine makers posts shallower-than-expected loss…

These Stocks Are Moving the Most Today: Qualcomm, DJT, Arm, Moderna, SolarEdge, Lyft, Zillow, AppLovin, Wolfspeed, and More

…

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last…

Moderna reports surprise profit on higher-than-expected COVID vaccine sales By Reuters

Moderna reports surprise profit on higher-than-expected COVID vaccine sales…

Moderna CEO Bancel steps down as sales chief, Bloomberg Law reports By Reuters

Moderna CEO Bancel steps down as sales chief, Bloomberg Law reports…

08:46: Moderna: Break-even auf absehbare Zeit nicht in Sicht!

Der Aktienkurs von Moderna befindet sich seit dem 1. August 2024 in einem Abwärtstrend. Bis in das Jahr 2026 sind…

Moderna Aktie: Kursziel wegen kurzfristigen Herausforderungen reduziert

Zürich (www.aktiencheck.de) - Moderna-Aktienanalyse von der UBS: Aktuelle Bewertung UBS hat das Kursziel für die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…

Moderna Aktie: Wachsender Wettbewerb und regulatorische Hürden - Bernstein mit vorsichtiger Einschätzung

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Sanford C. Bernstein & Co: Aktuelle Bewertung Das US-Analysehaus Bernstein hat die Berichterstattung über Moderna Inc.…

NFLX, TSM, AXP, MRNA, TSLA: Top 5 Trending Stocks Today - American Express (NYSE:AXP), Moderna (NASDAQ:MRNA)

S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05.…

Moderna Stock Falls 20% in a Month: Time to Sell or Hold?

Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point…

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines By Reuters

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines…

MRNA DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

October 8, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRNA

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

Moderna, Cenra Healthcare enter JV to promote mRNA respiratory vaccine in Taiwan

…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)…

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Metagenomi Inc.

Robbins LLP is Investigating Allegations that Metagenomi Inc. (MGX) Misled Investors Regarding its Relationship with Moderna, Inc.…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Down 13% in 1 Day, Is Moderna Stock in Trouble?

Theres no hope of it recovering to its prior heights anytime soon.…

Down 13% in 1 Day, Is Moderna Stock in Trouble? @themotleyfool #stocks $MRNA

Theres no hope of it recovering to its prior heights anytime soon.…

Moderna: Still Bullish View

…

Moderna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline

Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine…

Moderna: Aktie springt hoch – das beflügelt

Die Moderna-Aktie stieg am Dienstag um über vier Prozent.…

Moderna: Zulassung des aktualisierten Covid-19-Impfstoffs durch Health Canada - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Lost Money on Moderna, Inc. (MRNA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna"…